177 related articles for article (PubMed ID: 29140576)
1. Comparison between qualitative and quantitative assessment of background parenchymal enhancement on breast MRI.
Pujara AC; Mikheev A; Rusinek H; Gao Y; Chhor C; Pysarenko K; Rallapalli H; Walczyk J; Moccaldi M; Babb JS; Melsaether AN
J Magn Reson Imaging; 2018 Jun; 47(6):1685-1691. PubMed ID: 29140576
[TBL] [Abstract][Full Text] [Related]
2. Machine learning-based prediction of future breast cancer using algorithmically measured background parenchymal enhancement on high-risk screening MRI.
Saha A; Grimm LJ; Ghate SV; Kim CE; Soo MS; Yoon SC; Mazurowski MA
J Magn Reson Imaging; 2019 Aug; 50(2):456-464. PubMed ID: 30648316
[TBL] [Abstract][Full Text] [Related]
3. Does breast MRI background parenchymal enhancement indicate metabolic activity? Qualitative and 3D quantitative computer imaging analysis.
Mema E; Mango VL; Guo X; Karcich J; Yeh R; Wynn RT; Zhao B; Ha RS
J Magn Reson Imaging; 2018 Mar; 47(3):753-759. PubMed ID: 28646614
[TBL] [Abstract][Full Text] [Related]
4. Fully Automatic Assessment of Background Parenchymal Enhancement on Breast MRI Using Machine-Learning Models.
Nam Y; Park GE; Kang J; Kim SH
J Magn Reson Imaging; 2021 Mar; 53(3):818-826. PubMed ID: 33219624
[TBL] [Abstract][Full Text] [Related]
5. Role of dynamic contrast-enhanced MRI in evaluating the association between contralateral parenchymal enhancement and survival outcome in ER-positive, HER2-negative, node-negative invasive breast cancer.
Shin GW; Zhang Y; Kim MJ; Su MY; Kim EK; Moon HJ; Yoon JH; Park VY
J Magn Reson Imaging; 2018 Dec; 48(6):1678-1689. PubMed ID: 29734483
[TBL] [Abstract][Full Text] [Related]
6. Fully automatic quantification of fibroglandular tissue and background parenchymal enhancement with accurate implementation for axial and sagittal breast MRI protocols.
Wei D; Jahani N; Cohen E; Weinstein S; Hsieh MK; Pantalone L; Kontos D
Med Phys; 2021 Jan; 48(1):238-252. PubMed ID: 33150617
[TBL] [Abstract][Full Text] [Related]
7. Gadoteridol-enhanced MRI of the breast: can contrast agent injection rate impact background parenchymal enhancement?
Marzocca F; Moffa G; Landi VN; Panzironi G; Kirchin MA; Pediconi F; Galati F
Acta Radiol; 2022 Sep; 63(9):1173-1179. PubMed ID: 34323589
[TBL] [Abstract][Full Text] [Related]
8. Three-Dimensional Quantitative Validation of Breast Magnetic Resonance Imaging Background Parenchymal Enhancement Assessments.
Ha R; Mema E; Guo X; Mango V; Desperito E; Ha J; Wynn R; Zhao B
Curr Probl Diagn Radiol; 2016; 45(5):297-303. PubMed ID: 27039221
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Assessment of Breast Parenchymal Uptake on 18F-FDG PET/CT: Correlation with Age, Background Parenchymal Enhancement, and Amount of Fibroglandular Tissue on MRI.
Leithner D; Baltzer PA; Magometschnigg HF; Wengert GJ; Karanikas G; Helbich TH; Weber M; Wadsak W; Pinker K
J Nucl Med; 2016 Oct; 57(10):1518-1522. PubMed ID: 27230924
[TBL] [Abstract][Full Text] [Related]
11. Inter- and intrareader agreement for categorization of background parenchymal enhancement at baseline and after training.
Melsaether A; McDermott M; Gupta D; Pysarenko K; Shaylor SD; Moy L
AJR Am J Roentgenol; 2014 Jul; 203(1):209-15. PubMed ID: 24951217
[TBL] [Abstract][Full Text] [Related]
12. Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response.
Onishi N; Li W; Newitt DC; Harnish RJ; Strand F; Nguyen AA; Arasu VA; Gibbs J; Jones EF; Wilmes LJ; Kornak J; Joe BN; Price ER; Ojeda-Fournier H; Eghtedari M; Zamora KW; Woodard S; Umphrey HR; Nelson MT; Church AL; Bolan PJ; Kuritza T; Ward K; Morley K; Wolverton D; Fountain K; Lopez Paniagua D; Hardesty L; Brandt KR; McDonald ES; Rosen M; Kontos D; Abe H; Sheth D; Crane E; Dillis C; Sheth P; Hovanessian-Larsen L; Bang DH; Porter B; Oh KY; Jafarian N; Tudorica LA; Niell B; Drukteinis J; Newell MS; Giurescu ME; Berman E; Lehman CD; Partridge SC; Fitzpatrick KA; Borders MH; Yang WT; Dogan B; Goudreau SH; Chenevert T; Yau C; DeMichele A; Berry DA; Esserman LJ; Hylton NM
Radiology; 2021 Nov; 301(2):295-308. PubMed ID: 34427465
[TBL] [Abstract][Full Text] [Related]
13. Background parenchymal enhancement over exam time in patients with and without breast cancer.
Melsaether A; Pujara AC; Elias K; Pysarenko K; Gudi A; Dodelzon K; Babb JS; Gao Y; Moy L
J Magn Reson Imaging; 2017 Jan; 45(1):74-83. PubMed ID: 27285396
[TBL] [Abstract][Full Text] [Related]
14. Breast MRI Background Parenchymal Enhancement Categorization Using Deep Learning: Outperforming the Radiologist.
Eskreis-Winkler S; Sutton EJ; D'Alessio D; Gallagher K; Saphier N; Stember J; Martinez DF; Morris EA; Pinker K
J Magn Reson Imaging; 2022 Oct; 56(4):1068-1076. PubMed ID: 35167152
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Measures of Background Parenchymal Enhancement Predict Breast Cancer Risk.
Niell BL; Abdalah M; Stringfield O; Raghunand N; Ataya D; Gillies R; Balagurunathan Y
AJR Am J Roentgenol; 2021 Jul; 217(1):64-75. PubMed ID: 32876474
[No Abstract] [Full Text] [Related]
16. Evaluation of background parenchymal enhancement on breast MRI: a systematic review.
Bignotti B; Signori A; Valdora F; Rossi F; Calabrese M; Durando M; Mariscotto G; Tagliafico A
Br J Radiol; 2017 Feb; 90(1070):20160542. PubMed ID: 27925480
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of background parenchymal enhancement in whole breast on MRI: Influence of menstrual cycle and comparison with a qualitative analysis.
Jung Y; Jeong SK; Kang DK; Moon Y; Kim TH
Eur J Radiol; 2018 Jun; 103():84-89. PubMed ID: 29803391
[TBL] [Abstract][Full Text] [Related]
18. Background parenchymal enhancement assessment: Inter- and intra-rater reliability across breast MRI sequences.
Bignotti B; Calabrese M; Signori A; Tosto S; Valdora F; Tagliafico A; Durando M; Mariscotti G
Eur J Radiol; 2019 May; 114():57-61. PubMed ID: 31005177
[TBL] [Abstract][Full Text] [Related]
19. Quantitative evaluation of background parenchymal enhancement (BPE) on breast MRI. A feasibility study with a semi-automatic and automatic software compared to observer-based scores.
Tagliafico A; Bignotti B; Tagliafico G; Tosto S; Signori A; Calabrese M
Br J Radiol; 2015; 88(1056):20150417. PubMed ID: 26462852
[TBL] [Abstract][Full Text] [Related]
20. DCE-MRI Background Parenchymal Enhancement Quantified from an Early versus Delayed Post-contrast Sequence: Association with Breast Cancer Presence.
Wu S; Zuley ML; Berg WA; Kurland BF; Jankowitz RC; Sumkin JH; Gur D
Sci Rep; 2017 May; 7(1):2115. PubMed ID: 28522877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]